← Leaderboards
Urs Oschner
Crestone, Inc.
$8,499,692
Attributed
$8,499,692
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.6M · FY2024–25$5M$3.8M$2.5M$1.3M$0
'24
'25
Funding mix
By agency
NIH$8,499,692 · 1
By mechanism
N01$8,499,692 · 1
Top collaborators
No co-investigators on record.
Most similar at Crestone, Inc.
Same institution · by research overlap
- Thale Cross Jarvis$6,890,861
- Urs Ochsner$40,390,611
- Mary Ann Degroote$813,744
- Jarvis Thale$5,951,244
- Urs Arnold Ochsner$1,724,814
Others in their field
Other Rising Stars on “Advanced Development”
- Kiran Datta · Leidos Biomedical Research, Inc.$277,585,346
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
Advanced DevelopmentSafety AssessmentTherapeutic CandidateTherapeutic DevelopmentBacterial Drug ResistanceBacterial ResistanceBiodefenseCandidate SelectionChemistryClinical AssessmentsClostridium DifficileCombating Antibiotic Resistant BacteriaEfficacy EvaluationEmerging Communicable DiseasesLead OptimizationManufacturePathogenPhase I Clinical TrialsPre-ClinicalProduct DevelopmentResearch And DevelopmentResearch SupportAntimicrobial Resistant InfectionInfection